Publications by authors named "Jillian Haywood"

Article Synopsis
  • In-hospital mortality rates for patients experiencing cardiogenic shock remain high, even with advanced support devices like VA-ECMO and Impella.
  • A study analyzed blood samples from 11 patients before and after device implantation, focusing on changes in the plasma proteome using SOMAscan technology.
  • The findings indicated that both ECMO and Impella lead to reduced inflammatory markers and increased cell death among inflammatory cells, suggesting that these proteins could be potential targets for new treatments or biomarkers in managing acute myocardial circulatory support (AMCS).
View Article and Find Full Text PDF

Background: Cardiogenic shock occurring in the setting of advanced heart failure (HF-CS) is increasingly common. However, recent studies have focused almost exclusively on acute myocardial infarction-related CS. We sought to define clinical, hemodynamic, metabolic, and treatment parameters associated with clinical outcomes among patients with HF-CS, using data from the Cardiogenic Shock Working Group registry.

View Article and Find Full Text PDF

Objectives: The purpose of this study was to investigate the association between obtaining hemodynamic data from early pulmonary artery catheter (PAC) placement and outcomes in cardiogenic shock (CS).

Background: Although PACs are used to guide CS management decisions, evidence supporting their optimal use in CS is lacking.

Methods: The Cardiogenic Shock Working Group (CSWG) collected retrospective data in CS patients from 8 tertiary care institutions from 2016 to 2019.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluates the Society for Cardiovascular Angiography and Interventions (SCAI) stages to determine their effectiveness in predicting in-hospital mortality for patients with cardiogenic shock (CS).
  • Out of 1414 patients, those with myocardial infarction had a significantly higher mortality rate (41%) compared to those with heart failure (26%).
  • The research indicates that increasing SCAI stages correspond with higher mortality risks, and elevated biventricular filling pressures indicate severe hemodynamic congestion, suggesting better management strategies may be needed for high-risk CS patients.
View Article and Find Full Text PDF